Author:
Hoffmann T. K.,Whiteside T. L.,Bier H.
Publisher
Springer Science and Business Media LLC
Reference169 articles.
1. Agarwala S, Vlock D, Johnson JT et al. (1991) Phase II trial of interferon-alpha in locally recurrent or metastatic head and neck cancer: results of ECOG trial P-Z386. Proc Am Soc Clin Oncol 10: 205
2. Albanell J, Rojo F, Averbuch S et al. (2002) Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 20: 110?124
3. Almand B, Resser JR, Lindman B et al. (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6: 1755?1766
4. Almand B, Clark JI, Nikitina E et al. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 166: 678?689
5. Amiel JL, Sancho-Garnier H, Vanderbrouck C et al. (1979) First results of a randomized trial on immunotherapy of head and neck tumors. Recent Results Cancer Res 68: 318?323
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献